PMC:7696151 / 70331-70639
Annnotations
{"target":"https://pubannotation.org/docs/sourcedb/PMC/sourceid/7696151","sourcedb":"PMC","sourceid":"7696151","source_url":"https://www.ncbi.nlm.nih.gov/pmc/7696151","text":"The efficacy of treatment is due to the ability of drugs to alter the expression of urinary and immune cell micro RNA that contribute to lupus progression by post-transcriptional modulation of genes involved in the immune response, pro-inflammatory cytokines production and toll-like receptor pathways [129].","tracks":[{"project":"LitCovid-PubTator","denotations":[{"id":"2048","span":{"begin":137,"end":142},"obj":"Disease"}],"attributes":[{"id":"A2048","pred":"tao:has_database_id","subj":"2048","obj":"MESH:D008180"},{"subj":"2048","pred":"source","obj":"LitCovid-PubTator"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}]},{"project":"LitCovid-sentences","denotations":[{"id":"T447","span":{"begin":0,"end":308},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"T447","pred":"source","obj":"LitCovid-sentences"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"LitCovid-PubTator","color":"#ece793","default":true},{"id":"LitCovid-sentences","color":"#cd93ec"}]}]}}